![OVM Pipeline November 2023](https://www.oxfordvacmedix.com/wp-content/uploads/2023/11/OVM-Pipeline-Nov-23.jpg)
The graphic above shows the research and development plans for Oxford Vacmedix UK.
.
- OVM-100 is a cancer vaccine targeting HPV related tumours such as cervical cancer and head and neck cancer
,
- OVM-200 is a cancer vaccine targeting survivin (inhibitor of apoptosis protein) over expressed in most solid tumours including lung, breast, prostate and ovarian cancers.
![biffbar lux 5500 puffs strawberry kiwi disposable](https://www.oxfordvacmedix.com/wp-content/uploads/2022/10/OVM-Pipeline-Oct-22-1024x576.jpg)